69 months of biweekly injections alongside caloric restriction and GLP-1 therapy has shown resolution of NAFLD in case series published by bariatric medicine practices
In the SURMOUNT-5 head-to-head comparison with semaglutide, tirzepatide produced approximately 20% greater body weight reduction, establishing it as the more potent weight loss agent currently available.[5] PCOS-specific RCT data for tirzepatide is less mature than for semaglutide no large completed trials in PCOS populations exist as of early 2026 but the mechanistic case is compelling
Practice portion control through deliberate plating rather than relying on appetite suppression
What are the possible Complications of Labial Melanotic Macules
arrow_forward Semaglutide is also known as Ozempic, which is used for diabetes management
Raun and colleagues characterised it as the first selective growth hormone secretagogue: it released GH from rat pituitary cells with potency and efficacy similar to GHRP-6, but unlike GHRP-6 and GHRP-2, both of which raised ACTH and cortisol ipamorelin did not release ACTH or cortisol at levels significantly different from GHRH stimulation, even at doses more than 200-fold above its ED50 for GH release [7]